81/100B547.03
USD
4.03
(0.74%)
Pre Open·549.72USD+2.69(+0.49%)
Last updated: · Delayed 15 min
Vertex Pharmaceuticals total debt 1990–2026What is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Vertex Pharmaceuticals's total debt was 6.48B USD on 30 September 2026, up 253.1% on a year before. At the end of fiscal year 2025 it was 3.88B USD.
Last updated 9 Nov 2026 · Next report 11 Feb 2027
Total debt
Growth
| Fiscal year | Period ending | Total debt | Growth | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 6.48B | +253.08% | 6.30B | -175.10M | 0.31 |
| FY2025 | 31 Dec 2025 | 3.88B | +121.92% | 6.61B | 2.73B | 0.21 |
| FY2024 | 31 Dec 2024 | 1.75B | +116.42% | 6.12B | 4.37B | 0.11 |
| FY2023 | 31 Dec 2023 | 808.40M | -10.15% | 11.22B | 10.41B | 0.05 |
| FY2022 | 31 Dec 2022 | 899.70M | -7.00% | 10.78B | 9.88B | 0.06 |
| FY2021 | 31 Dec 2021 | 967.40M | +3.81% | 7.52B | 6.56B | 0.10 |
| FY2020 | 31 Dec 2020 | 931.90M | +40.84% | 6.66B | 5.73B | 0.11 |
| FY2019 | 31 Dec 2019 | 661.66M | +12.75% | 3.81B | 3.15B | 0.11 |
| FY2018 | 31 Dec 2018 | 586.82M | -3.23% | 3.17B | 2.58B | 0.13 |
| FY2017 | 31 Dec 2017 | 606.43M | -27.87% | 2.09B | 1.48B | 0.30 |
| FY2016 | 31 Dec 2016 | 840.76M | +1.76% | 1.43B | 593.80M | 0.73 |
| FY2015 | 31 Dec 2015 | 826.24M | +0.16% | 1.04B | 216.22M | 0.88 |
| FY2014 | 31 Dec 2014 | 824.95M | +62.85% | 1.39B | 562.16M | 0.77 |
| FY2013 | 31 Dec 2013 | 506.58M | -27.31% | 1.47B | 958.49M | 0.37 |
| FY2012 | 31 Dec 2012 | 696.91M | +52.85% | 1.32B | 624.31M | 0.70 |
| FY2011 | 31 Dec 2011 | 455.95M | -15.09% | 968.92M | 512.97M | 0.58 |
| FY2010 | 31 Dec 2010 | 536.99M | +188.85% | 1.03B | 494.42M | 1.07 |
| FY2009 | 31 Dec 2009 | 185.91M | -35.34% | 1.28B | 1.10B | 0.17 |
| FY2008 | 31 Dec 2008 | 287.50M | +1,337.72% | 832.10M | 544.60M | 1.20 |
| FY2007 | 31 Dec 2007 | 20.00M | -83.84% | 460.87M | 440.87M | 0.07 |
| FY2006 | 31 Dec 2006 | 123.76M | -31.28% | 704.63M | 580.87M | 0.24 |
| FY2005 | 31 Dec 2005 | 180.10M | -46.24% | 361.16M | 181.06M | 0.75 |
| FY2004 | 31 Dec 2004 | 335.00M | -7.93% | 392.32M | 57.32M | 9.45 |
| FY2003 | 31 Dec 2003 | 363.85M | +10.88% | 583.16M | 219.32M | 1.89 |
| FY2002 | 31 Dec 2002 | 328.14M | +0.16% | 634.98M | 306.85M | 0.87 |
| FY2001 | 31 Dec 2001 | 327.61M | -9.59% | 743.20M | 415.60M | 0.69 |
| FY2000 | 31 Dec 2000 | 362.34M | +5,033.02% | 388.60M | 26.26M | 0.70 |
| FY1999 | 31 Dec 1999 | 7.06M | -27.97% | 31.50M | 24.44M | 0.03 |
| FY1998 | 31 Dec 1998 | 9.80M | +16.67% | 24.20M | 14.40M | 0.04 |
| FY1997 | 31 Dec 1997 | 8.40M | -1.18% | 71.50M | 63.10M | 0.03 |
| FY1996 | 31 Dec 1996 | 8.50M | +21.43% | 34.90M | 26.40M | 0.06 |
| FY1995 | 31 Dec 1995 | 7.00M | +9.38% | 28.40M | 21.40M | 0.08 |
| FY1994 | 31 Dec 1994 | 6.40M | +6.67% | 71.60M | 65.20M | 0.06 |
| FY1993 | 31 Dec 1993 | 6.00M | +17.65% | 28.60M | 22.60M | 0.12 |
| FY1992 | 31 Dec 1992 | 5.10M | +54.55% | 11.60M | 6.50M | 0.12 |
| FY1991 | 31 Dec 1991 | 3.30M | +3.13% | 27.60M | 24.30M | 0.06 |
| FY1990 | 31 Dec 1990 | 3.20M | — | 4.40M | 1.20M | 0.62 |
| Quarter | Period ending | Total debt | Growth on a year before | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 6.48B | +253.08% | 6.30B | -175.10M | 0.31 |
| Q2 FY2026 | 30 Jun 2026 | 1.98B | +29.47% | 7.85B | 5.87B | 0.10 |
| Q1 FY2026 | 31 Mar 2026 | 1.99B | +20.46% | 7.25B | 5.26B | 0.10 |
| Q4 FY2025 | 31 Dec 2025 | 3.88B | +121.92% | 6.61B | 2.73B | 0.21 |
| Q3 FY2025 | 30 Sept 2025 | 1.83B | +7.75% | 6.29B | 4.45B | 0.11 |
| Q2 FY2025 | 30 Jun 2025 | 1.53B | +63.64% | 6.38B | 4.86B | 0.09 |
| Q1 FY2025 | 31 Mar 2025 | 1.65B | +128.63% | 6.20B | 4.55B | 0.10 |
| Q4 FY2024 | 31 Dec 2024 | 1.75B | +116.42% | 6.12B | 4.37B | 0.11 |
| Q3 FY2024 | 30 Sept 2024 | 1.70B | +128.67% | 6.52B | 4.82B | 0.11 |
| Q2 FY2024 | 30 Jun 2024 | 933.40M | +21.60% | 5.80B | 4.86B | 0.06 |
| Q1 FY2024 | 31 Mar 2024 | 721.30M | -8.60% | 10.17B | 9.45B | 0.04 |
| Q4 FY2023 | 31 Dec 2023 | 808.40M | -10.15% | 11.22B | 10.41B | 0.05 |
| Q3 FY2023 | 30 Sept 2023 | 744.70M | -9.69% | 11.93B | 11.18B | 0.05 |
| Q2 FY2023 | 30 Jun 2023 | 767.60M | -9.41% | 11.24B | 10.47B | 0.05 |
| Q1 FY2023 | 31 Mar 2023 | 789.20M | -9.55% | 10.41B | 9.62B | 0.05 |
| Q4 FY2022 | 31 Dec 2022 | 899.70M | -7.00% | 10.78B | 9.88B | 0.06 |
| Q3 FY2022 | 30 Sept 2022 | 824.60M | -5.95% | 9.77B | 8.95B | 0.06 |
| Q2 FY2022 | 30 Jun 2022 | 847.30M | -5.21% | 9.25B | 8.41B | 0.07 |
| Q1 FY2022 | 31 Mar 2022 | 872.50M | -2.93% | 8.24B | 7.37B | 0.08 |
| Q4 FY2021 | 31 Dec 2021 | 967.40M | +3.81% | 7.52B | 6.56B | 0.10 |
| Q3 FY2021 | 30 Sept 2021 | 876.80M | +60.44% | 6.96B | 6.08B | 0.09 |
| Q2 FY2021 | 30 Jun 2021 | 893.85M | +71.21% | 6.71B | 5.81B | 0.10 |
| Q1 FY2021 | 31 Mar 2021 | 898.80M | +68.65% | 6.92B | 6.03B | 0.10 |
| Q4 FY2020 | 31 Dec 2020 | 931.90M | +40.84% | 6.66B | 5.73B | 0.11 |
| Q3 FY2020 | 30 Sept 2020 | 546.51M | -9.60% | 6.15B | 5.60B | 0.07 |
| Q2 FY2020 | 30 Jun 2020 | 522.07M | -14.69% | 5.45B | 4.93B | 0.07 |
| Q1 FY2020 | 31 Mar 2020 | 532.95M | -14.57% | 4.19B | 3.66B | 0.08 |
| Q4 FY2019 | 31 Dec 2019 | 661.66M | +12.75% | 3.81B | 3.15B | 0.11 |
| Q3 FY2019 | 30 Sept 2019 | 604.54M | +2.81% | 4.00B | 3.39B | 0.12 |
| Q2 FY2019 | 30 Jun 2019 | 611.96M | +3.24% | 3.95B | 3.34B | 0.12 |
| Q1 FY2019 | 31 Mar 2019 | 623.87M | +4.83% | 3.48B | 2.85B | 0.13 |
| Q4 FY2018 | 31 Dec 2018 | 586.82M | -3.23% | 3.17B | 2.58B | 0.13 |
| Q3 FY2018 | 30 Sept 2018 | 588.04M | +0.14% | 3.06B | 2.47B | 0.20 |
| Q2 FY2018 | 30 Jun 2018 | 592.74M | +4.25% | 2.77B | 2.18B | 0.22 |
| Q1 FY2018 | 31 Mar 2018 | 595.13M | +8.52% | 2.48B | 1.88B | 0.25 |
| Q4 FY2017 | 31 Dec 2017 | 606.43M | -27.87% | 2.09B | 1.48B | 0.30 |
| Q3 FY2017 | 30 Sept 2017 | 587.19M | -28.42% | 1.81B | 1.23B | 0.33 |
| Q2 FY2017 | 30 Jun 2017 | 568.54M | -30.72% | 1.67B | 1.10B | 0.34 |
| Q1 FY2017 | 31 Mar 2017 | 548.40M | -33.49% | 1.41B | 860.38M | 0.37 |
| Q4 FY2016 | 31 Dec 2016 | 840.76M | +1.76% | 1.43B | 593.80M | 0.73 |
| Q3 FY2016 | 30 Sept 2016 | 820.32M | -0.08% | 1.13B | 308.13M | 0.80 |
| Q2 FY2016 | 30 Jun 2016 | 820.63M | -0.46% | 1.07B | 250.80M | 0.84 |
| Q1 FY2016 | 31 Mar 2016 | 824.49M | -1.13% | 1.03B | 201.12M | 0.86 |
| Q4 FY2015 | 31 Dec 2015 | 826.24M | +0.16% | 1.04B | 216.22M | 0.88 |
| Q3 FY2015 | 30 Sept 2015 | 820.98M | -0.88% | 1.01B | 184.85M | 0.89 |
| Q2 FY2015 | 30 Jun 2015 | 824.47M | +53.24% | 1.02B | 191.98M | 0.92 |
| Q1 FY2015 | 31 Mar 2015 | 833.91M | +54.09% | 1.18B | 347.23M | 0.85 |
| Q4 FY2014 | 31 Dec 2014 | 824.95M | +62.85% | 1.39B | 562.16M | 0.77 |
| Q3 FY2014 | 30 Sept 2014 | 828.24M | +85.55% | 1.48B | 649.50M | 0.72 |
| Q2 FY2014 | 30 Jun 2014 | 538.03M | +35.23% | 1.22B | 681.13M | 0.46 |
| Q1 FY2014 | 31 Mar 2014 | 541.18M | -26.86% | 1.32B | 783.02M | 0.44 |
| Q4 FY2013 | 31 Dec 2013 | 506.58M | -27.31% | 1.47B | 958.49M | 0.37 |
| Q3 FY2013 | 30 Sept 2013 | 446.38M | +11.59% | 1.42B | 976.27M | 0.35 |
| Q2 FY2013 | 30 Jun 2013 | 397.85M | -0.54% | 1.43B | 1.03B | 0.30 |
| Q1 FY2013 | 31 Mar 2013 | 739.88M | +84.97% | 1.24B | 499.48M | 0.99 |
| Q4 FY2012 | 31 Dec 2012 | 696.91M | +52.85% | 1.32B | 624.31M | 0.70 |
| Q3 FY2012 | 30 Sept 2012 | 400.00M | -19.75% | 1.30B | 898.54M | 0.39 |
| Q2 FY2012 | 30 Jun 2012 | 400.00M | -19.14% | 1.22B | 823.33M | 0.39 |
| Q1 FY2012 | 31 Mar 2012 | 400.00M | -18.72% | 980.87M | 580.87M | 0.43 |
| Q4 FY2011 | 31 Dec 2011 | 455.95M | -15.09% | 968.92M | 512.97M | 0.58 |
| Q3 FY2011 | 30 Sept 2011 | 498.42M | +2.30% | 658.69M | 160.27M | 0.86 |
| Q2 FY2011 | 30 Jun 2011 | 494.66M | +472.48% | 593.49M | 98.83M | 1.61 |
| Q1 FY2011 | 31 Mar 2011 | 492.10M | +292.69% | 823.45M | 331.35M | 1.26 |
| Q4 FY2010 | 31 Dec 2010 | 536.99M | +188.85% | 1.03B | 494.42M | 1.07 |
| Q3 FY2010 | 30 Sept 2010 | 487.23M | +85.37% | 1.20B | 715.79M | 0.75 |
| Q2 FY2010 | 30 Jun 2010 | 86.41M | -40.00% | 979.15M | 892.74M | 0.10 |
| Q1 FY2010 | 31 Mar 2010 | 125.32M | -56.41% | 1.09B | 967.37M | 0.13 |
| Q4 FY2009 | 31 Dec 2009 | 185.91M | -35.34% | 1.28B | 1.10B | 0.17 |
| Q3 FY2009 | 30 Sept 2009 | 262.84M | -8.58% | 856.61M | 593.77M | 0.43 |
| Q2 FY2009 | 30 Jun 2009 | 144.00M | -49.91% | 754.36M | 610.36M | 0.20 |
| Q1 FY2009 | 31 Mar 2009 | 287.50M | 0.00% | 869.19M | 581.69M | 0.41 |
| Q4 FY2008 | 31 Dec 2008 | 287.50M | +1,337.72% | 832.10M | 544.60M | 1.20 |
| Q3 FY2008 | 30 Sept 2008 | 287.50M | +1,337.72% | 920.07M | 632.57M | 0.82 |
| Q2 FY2008 | 30 Jun 2008 | 287.50M | +362.97% | 832.06M | 544.56M | 1.20 |
| Q1 FY2008 | 31 Mar 2008 | 287.50M | +340.78% | 749.64M | 462.14M | 0.94 |
| Q4 FY2007 | 31 Dec 2007 | 20.00M | -83.84% | 460.87M | 440.87M | 0.07 |
| Q3 FY2007 | 30 Sept 2007 | 20.00M | -80.35% | 502.55M | 482.55M | 0.06 |
| Q2 FY2007 | 30 Jun 2007 | 62.10M | -65.52% | 592.97M | 530.87M | 0.15 |
| Q1 FY2007 | 31 Mar 2007 | 65.23M | -63.78% | 655.14M | 589.91M | 0.13 |
| Q4 FY2006 | 31 Dec 2006 | 123.76M | -31.28% | 704.63M | 580.87M | 0.24 |
| Q3 FY2006 | 30 Sept 2006 | 101.75M | -65.46% | 694.76M | 593.01M | 0.20 |
| Q2 FY2006 | 30 Jun 2006 | 180.09M | -46.24% | 262.34M | 82.25M | 1.03 |
| Q1 FY2006 | 31 Mar 2006 | 180.10M | -46.24% | 339.46M | 159.36M | 0.77 |
| Q4 FY2005 | 31 Dec 2005 | 180.10M | -46.24% | 361.16M | 181.06M | 0.75 |
| Q3 FY2005 | 30 Sept 2005 | 294.55M | -7.86% | 399.17M | 104.62M | 2.21 |
| Q2 FY2005 | 30 Jun 2005 | 335.00M | +3.84% | 446.61M | 111.61M | 2.72 |
| Q1 FY2005 | 31 Mar 2005 | 335.00M | +6.34% | 334.33M | -665.00K | — |
| Q4 FY2004 | 31 Dec 2004 | 335.00M | -7.93% | 392.32M | 57.32M | 9.45 |
| Q3 FY2004 | 30 Sept 2004 | 319.69M | -7.43% | 418.43M | 98.74M | 4.30 |
| Q2 FY2004 | 30 Jun 2004 | 322.61M | -5.33% | 460.37M | 137.76M | 2.93 |
| Q1 FY2004 | 31 Mar 2004 | 315.04M | -4.50% | 520.57M | 205.54M | 2.01 |
| Q4 FY2003 | 31 Dec 2003 | 363.85M | +10.88% | 583.16M | 219.32M | 1.89 |
| Q3 FY2003 | 30 Sept 2003 | 345.33M | +6.49% | 595.60M | 250.27M | 1.49 |
| Q2 FY2003 | 30 Jun 2003 | 340.78M | +4.77% | 633.40M | 292.62M | 1.09 |
| Q1 FY2003 | 31 Mar 2003 | 329.90M | +1.12% | 680.09M | 350.19M | 0.82 |
| Q4 FY2002 | 31 Dec 2002 | 328.14M | +0.16% | 634.98M | 306.85M | 0.87 |
| Q3 FY2002 | 30 Sept 2002 | 324.28M | -9.61% | 651.35M | 327.07M | 0.79 |
| Q2 FY2002 | 30 Jun 2002 | 325.25M | -6.71% | 679.85M | 354.60M | 0.74 |
| Q1 FY2002 | 31 Mar 2002 | 326.26M | -6.56% | 699.03M | 372.77M | 0.72 |
| Q4 FY2001 | 31 Dec 2001 | 327.61M | -9.59% | 743.20M | 415.60M | 0.69 |
| Q3 FY2001 | 30 Sept 2001 | 358.75M | -29.92% | 381.87M | 23.12M | 0.75 |
| Q2 FY2001 | 30 Jun 2001 | 348.65M | +92.81% | 320.03M | -28.62M | 0.91 |
| Q1 FY2001 | 31 Mar 2001 | 349.15M | +92.45% | 323.34M | -25.82M | 0.89 |
| Q4 FY2000 | 31 Dec 2000 | 362.34M | +5,033.02% | 388.60M | 26.26M | 0.70 |
| Q3 FY2000 | 30 Sept 2000 | 511.92M | +6,463.09% | 713.35M | 201.43M | 2.26 |
| Q2 FY2000 | 30 Jun 2000 | 180.82M | +2,052.65% | 378.39M | 197.56M | 0.80 |
| Q1 FY2000 | 31 Mar 2000 | 181.43M | +1,893.70% | 347.25M | 165.82M | 0.90 |
| Q4 FY1999 | 31 Dec 1999 | 7.06M | -27.97% | 31.50M | 24.44M | 0.03 |
| Q3 FY1999 | 30 Sept 1999 | 7.80M | -25.00% | 188.10M | 180.30M | 0.04 |
| Q2 FY1999 | 30 Jun 1999 | 8.40M | -12.50% | 11.20M | 2.80M | 0.04 |
| Q1 FY1999 | 31 Mar 1999 | 9.10M | +4.60% | 19.80M | 10.70M | 0.04 |
| Q4 FY1998 | 31 Dec 1998 | 9.80M | +16.67% | 24.20M | 14.40M | 0.04 |
| Q3 FY1998 | 30 Sept 1998 | 10.40M | +26.83% | 49.70M | 39.30M | 0.04 |
| Q2 FY1998 | 30 Jun 1998 | 9.60M | +17.07% | 36.30M | 26.70M | 0.04 |
| Q1 FY1998 | 31 Mar 1998 | 8.70M | +7.41% | 58.40M | 49.70M | 0.03 |
| Q4 FY1997 | 31 Dec 1997 | 8.40M | -1.18% | 71.50M | 63.10M | 0.03 |
| Q3 FY1997 | 30 Sept 1997 | 8.20M | +18.84% | 177.20M | 169.00M | 0.03 |
| Q2 FY1997 | 30 Jun 1997 | 8.20M | +18.84% | 188.60M | 180.40M | 0.03 |
| Q1 FY1997 | 31 Mar 1997 | 8.10M | +24.62% | 84.90M | 76.80M | 0.03 |
| Q4 FY1996 | 31 Dec 1996 | 8.50M | +21.43% | 34.90M | 26.40M | 0.06 |
| Q3 FY1996 | 30 Sept 1996 | 6.90M | +1.47% | 39.10M | 32.20M | 0.05 |
| Q2 FY1996 | 30 Jun 1996 | 6.90M | 0.00% | 9.30M | 2.40M | 0.11 |
| Q1 FY1996 | 31 Mar 1996 | 6.50M | -1.52% | 20.20M | 13.70M | 0.08 |
| Q4 FY1995 | 31 Dec 1995 | 7.00M | +9.38% | 28.40M | 21.40M | 0.08 |
| Q3 FY1995 | 30 Sept 1995 | 6.80M | +7.94% | 39.40M | 32.60M | 0.08 |
| Q2 FY1995 | 30 Jun 1995 | 6.90M | +15.00% | 44.10M | 37.20M | 0.07 |
| Q1 FY1995 | 31 Mar 1995 | 6.60M | +20.00% | 51.40M | 44.80M | 0.07 |
| Q4 FY1994 | 31 Dec 1994 | 6.40M | +6.67% | 71.60M | 65.20M | 0.06 |
| Q3 FY1994 | 30 Sept 1994 | 6.30M | +6.78% | 48.50M | 42.20M | 0.07 |
| Q2 FY1994 | 30 Jun 1994 | 6.00M | +1.69% | 21.30M | 15.30M | 0.06 |
| Q1 FY1994 | 31 Mar 1994 | 5.50M | +3.77% | 54.30M | 48.80M | 0.05 |
| Q4 FY1993 | 31 Dec 1993 | 6.00M | +17.65% | 28.60M | 22.60M | 0.12 |
| Q3 FY1993 | 30 Sept 1993 | 5.90M | +18.00% | 15.00M | 9.10M | 0.15 |
| Q2 FY1993 | 30 Jun 1993 | 5.90M | +34.09% | 6.50M | 600.00K | 0.14 |
| Q1 FY1993 | 31 Mar 1993 | 5.30M | +47.22% | 15.00M | 9.70M | 0.13 |
| Q4 FY1992 | 31 Dec 1992 | 5.10M | +54.55% | 11.60M | 6.50M | 0.12 |
| Q3 FY1992 | 30 Sept 1992 | 5.00M | +42.86% | 22.70M | 17.70M | 0.11 |
| Q2 FY1992 | 30 Jun 1992 | 4.40M | +25.71% | 16.30M | 11.90M | 0.09 |
| Q1 FY1992 | 31 Mar 1992 | 3.60M | — | 24.80M | 21.20M | 0.07 |
| Q4 FY1991 | 31 Dec 1991 | 3.30M | +3.13% | 27.60M | 24.30M | 0.06 |
| Q3 FY1991 | 30 Sept 1991 | 3.50M | — | 7.40M | 3.90M | 0.13 |
| Q2 FY1991 | 30 Jun 1991 | 3.50M | — | 2.30M | -1.20M | 1.35 |
| Q4 FY1990 | 31 Dec 1990 | 3.20M | — | 4.40M | 1.20M | 0.62 |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
Total debt counts commercial paper, term debt and lease liabilities.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet
Common questions about Vertex Pharmaceuticals's debt
Source: Financial Modeling Prep